Fair to say there were was as well higher expectations for an increase in the Market Cap in early '22 after IHL completed its POC Phase 2 Trial into IHL-42X CLICK ON THE IMAGE TO ENLARGE.
Longer-Term investors may have an increase in expectations when the next Phase 2/3 Trial commences soonish. It will be interesting to see if past performances are any gauge for the future.
--------------------------------------------------------------------------------------------------------------------------- Apart from published milestones; Updates I am watching out for.
>> Reverse "over liquid" ASX to resolve the "lack of liquidity" on the Nasdaq. Quote from Joel "volumes on Nasdaq are currently less than on the ASX, we potentially foresee a time whereby this situation is reversed" https://stocknessmonster.com/announcements/ihl.asx-3A608385/
>> Manufacturing Update from Eurofins re manufacture and test chewable products to alleviate nicotine and opioid addiction. https://stocknessmonster.com/announcements/ihl.asx-3A608255/ >> CRO Update - Quest Pharmaceutical Services (‘QPS’) to provide regulatory advice and manage clinical trials for the development of CannQuit™ and ReneCann™ products for addiction and immune-disordered skin diseases. https://stocknessmonster.com/announcements/ihl.asx-3A616480/
>> Clarion Clinics - Update on Abbotsford "Model Clinic" ... location..fitout..premises to be ready before September.....update on supply of psilocybin & MDMA from Pharmala? TGA Requirements.. HREC approval? https://stocknessmonster.com/announcements/ihl.asx-3A617811/
3rd March > Incannex has engaged Catalent for the development and cGMP manufacture of Incannex’s own psilocybin drug product. Development of the drug product includes generation of the necessary quality and stability data to support future regulatory filings including IND applications. https://stocknessmonster.com/announcements/ihl.asx-3A614236/
Moving forward.....events that could raise "investor expectations" for Incannex and a possible increase in its' Market Cap Value?
A. IHL-42X - 2023-24
>> IHL-42X - Opening Clinical Trials for Phase 2/3 in the U.S.A. Sleep Clinics will raise the Profile of IHL-42X as a possible alternative medication for OSA >> IHL-42X - Preliminary Trial Results from USA Trials from Phase 2 (with success), then progressing immediately into Phase 3 will also raise the profile.
B. PSI-GAD 2023-24
>> Completion of the Phase 2 Monash Trial by the end of the year and the possible release of the results early next year will raise the profile of PSI as a possible therapy for GAD.
And with what appears to be mostly bi-partisan support for Psychedelics Therapies in US politics that bodes well too for a lead into the opening of an IND with the FDA around the same time as MAPS PBC receiving approval from the FDA for its MDMA Treatment for PTSD, with approx 1.9M Veterans eligible for treatment. As I have said previously there is commentary stating that any FDA approval for any indications using any Psychedelics will be worth Billions for that company and lift the profile of the whole Pyschedelics Industry.
C. Psychedelics Clinics 2023-4
>> Peter Widdows's reputation precedes him! Read up on his experience.
Plans have been made to use clinics as Real World Research Labs, and refer to commentary from @Flectional too. As @rhino78 I think mentioned recently, our clinics will be available to treat other patients for other indications also. Some Clinics in the USA such as those operated by Numinous (https://numinus.com/) have had some positive feedback for the services they provide to the Psychedelics Industry. Our Psychennex Clinics will lift the PUBLIC profile of our PSI-GAD program, subject to the success of the trial and the opening of the 1st clinic by the end of the year. Expectations could also be lifted for the whole Psychedelics industry with MAPS submitting their NDA with the FDA to treat PTSD with MDMA around Q3, 2023 and FDA approval around Q.1 - Q.2 2024.
---------------------------------------------------------------------------------------------------------------------------- I hope the items that I have referenced will be of some assistance to new investors wanting to do their own due diligence on Incannex. Please tag me if I can be of further assistance with any fundamentals!!!
GLAH
IHL Price at posting:
10.0¢ Sentiment: Buy Disclosure: Held
